Skip to main content
Fig. 2 | Clinical Epigenetics

Fig. 2

From: DNA methylation is differentially associated with glycemic outcomes by different types of weight-loss interventions: an epigenome-wide association study

Fig. 2

Manhattan plots depicting CpGs differentially associated with changes in glycemic measures, RYGB versus IMI. Baseline DNA methylation was differentially associated with changes in FPG (top), and HbA1c (bottom). The dashed line represents the suggestive significance threshold of P = 1.0 × 10−5. Abbreviations: FPG—fasting plasma glucose; HbA1c—hemoglobin A1c; IMI—intensive medical intervention; RYGB—Roux-en-Y gastric bypass

Back to article page